These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 571543)

  • 1. Effects of the irreversible inhibition of GABA transaminase upon some morphine effects.
    Contreras E; Tamayo L; Quijada L
    Neuropharmacology; 1979 Mar; 18(3):309-13. PubMed ID: 571543
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of inhibitors of GABA transaminase on the synthesis, binding, uptake, and metabolism of GABA.
    Löscher W
    J Neurochem; 1980 Jun; 34(6):1603-8. PubMed ID: 7381487
    [No Abstract]   [Full Text] [Related]  

  • 3. Irreversible inhibitors of GABA transaminase induce antinociceptive effects and potentiate morphine.
    Buckett WR
    Neuropharmacology; 1980 Aug; 19(8):715-22. PubMed ID: 7191489
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of 4-amino hex-5-ynoic acid (gamma-acetylenic GABA, gammma-ethynyl GABA) a catalytic inhibitor of GABA transaminase, on brain GABA metabolism in vivo.
    Jung MJ; Lippert B; Metcalf BW; Schechter PJ; Böhlen P; Sjoerdsma A
    J Neurochem; 1977 Apr; 28(4):717-23. PubMed ID: 894280
    [No Abstract]   [Full Text] [Related]  

  • 5. Attempts to correlate alterations in brain GABA metabolism by GABA-T inhibitors with their anticonvulsant effects.
    Schechter PJ; Tranier Y; Grove J
    Adv Exp Med Biol; 1979; 123():43-57. PubMed ID: 517278
    [No Abstract]   [Full Text] [Related]  

  • 6. Induction of analgesia and morphine potentiation by irreversible inhibitors of GABA-transaminase [proceedings].
    Buckett WR
    Br J Pharmacol; 1980 Jan; 68(1):129P-130P. PubMed ID: 7357148
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of isolation-induced aggressive behavior with GABA transaminase inhibitors.
    DaVanzo JP; Sydow M
    Psychopharmacology (Berl); 1979 Mar; 62(1):23-7. PubMed ID: 108744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-(5'-Phosphopyridoxyl)-4-aminobutyric acid: a stabel bisubstrate adduct inhibitor of rat brain 4-aminobutyric acid aminotransferase.
    Tunnicliff G; Ngo TT; Barbeau A
    Experientia; 1977 Jan; 33(1):20-2. PubMed ID: 836410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dyskinetic effects of intrastriatally injected GABA-transaminase inhibitors.
    Robin MM; Palfreyman MG; Schechter PJ
    Life Sci; 1979 Sep; 25(13):1103-9. PubMed ID: 513949
    [No Abstract]   [Full Text] [Related]  

  • 10. The role of GABA in analgesia and drug dependence.
    Buckett WR
    Rev Pure Appl Pharmacol Sci; 1981; 2(2):115-41. PubMed ID: 6276933
    [No Abstract]   [Full Text] [Related]  

  • 11. Catalytic inhibitors of GABA-transaminase as anticonvulsants in baboons with photosensitive epilepsy [proceedings].
    Horton RW; Meldrum BS
    Br J Pharmacol; 1978 Jun; 63(2):390P. PubMed ID: 96902
    [No Abstract]   [Full Text] [Related]  

  • 12. Audiogenic seizure protection by elevated brain GABA concentration in mice: effects of gamma-acetylenic gaba and gamma-vinyl GABA, two irreversible GABA-T inhibitors.
    Schechter PJ; Tranier Y; Jung MJ; Böhlen P
    Eur J Pharmacol; 1977 Oct; 45(4):319-28. PubMed ID: 923642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of a GABA transaminase inhibitor, gamma-vinyl GABA, on voluntary morphine consumption in the rat.
    Buckett WR
    Psychopharmacology (Berl); 1981; 75(2):214-6. PubMed ID: 6798609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. omega-Fluoromethyl analogues of omega-amino acids as irreversible inhibitors of 4-aminobutyrate:2-oxoglutarate aminotransferase.
    Bey P; Jung MJ; Gerhart F; Schirlin D; Van Dorsselaer V; Casara P
    J Neurochem; 1981 Nov; 37(5):1341-4. PubMed ID: 6795312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drugs affecting GABA.
    Seiler N; Sarhan S
    Prog Clin Biol Res; 1980; 39():425-39. PubMed ID: 7403190
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro and in vivo effects on brain GABA metabolism of (S)-4-amino-5-fluoropentanoic acid, a mechanism-based inactivator of gamma-aminobutyric acid transaminase.
    Silverman RB; Muztar AJ; Levy MA; Hirsch JD
    Life Sci; 1983 Jun; 32(24):2717-23. PubMed ID: 6855467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of inhibitors of GABA-transaminase for the determination of GABA turnover in mouse brain regions: an evaluation of aminooxyacetic acid and gabaculine.
    Bernasconi R; Maitre L; Martin P; Raschdorf F
    J Neurochem; 1982 Jan; 38(1):57-66. PubMed ID: 7108535
    [No Abstract]   [Full Text] [Related]  

  • 18. Di-n-propylacetate and GABA degradation. Preferential inhibition of succinic semialdehyde dehydrogenase and indirect inhibition of GABA-transaminase.
    van der Laan JW; de Boer T; Bruinvels J
    J Neurochem; 1979 Jun; 32(6):1769-80. PubMed ID: 376783
    [No Abstract]   [Full Text] [Related]  

  • 19. GABA transaminase inhibitors.
    Ciesielski L; Simler S; Gensburger C; Mandel P; Taillandier G; Benoit-Guyod JL; Boucherle A; Cohen-Addad C; Lajzerowicz J
    Adv Exp Med Biol; 1979; 123():21-41. PubMed ID: 390993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Inhibition of gamma-aminobutyric acid catabolism by valerenic acid derivatives].
    Riedel E; Hänsel R; Ehrke G
    Planta Med; 1982 Dec; 46(4):219-20. PubMed ID: 7163416
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.